Endocrine system and metabolic diseases articles from across Nature Portfolio

Endocrine systems and metabolic diseases affect the endocrine system and disrupt metabolism. Examples include diabetes and goiter.

Featured

News & Views | 30 May 2023

Zooming into process-specific risk
- Hannah Maude
- & Inês Cebola
Nature Metabolism 5, 730-731
News & Views | 23 May 2023

How can social jetlag affect health?
- Till Roenneberg
Nature Reviews Endocrinology 19, 383-384

Latest Research and Reviews

Research
01 June 2023 | Open Access

Protocol development to further differentiate and transition stem cell-derived pancreatic progenitors from a monolayer into endocrine cells in suspension culture
- Mitchell J. S. Braam
- , Jia Zhao
- & Timothy J. Kieffer
Scientific Reports 13, 8877
Research
31 May 2023 | Open Access

A versatile bioelectronic interface programmed for hormone sensing

Ultrasensitive, real-time profiling of bio-analytes is a prerequisite for precision medicine. Here, the authors present a versatile bio-electronic interface (VIBE) to sense signaling cascade-guided receptor-ligand interactions and show that it can detect hormone levels in blood samples and differentiate individual metabolic conditions.
- Preetam Guha Ray
- , Debasis Maity
- & Martin Fussenegger
Nature Communications 14, 3151
Research
30 May 2023 | Open Access

Transcriptional coactivation by EHMT2 restricts glucocorticoid-induced insulin resistance in a study with male mice

Glucocorticoids are known to induce insulin resistance via transcriptional activation of genes related to liver gluconeogenesis and insulin resistance. Here the authors report that in male mice treated with glucocorticoids, the transcriptional co-regulator EHMT2 is involved in the induction of Irs2 (a gene promoting insulin action) to restrict the extent of insulin resistance in the liver.
- Rebecca A. Lee
- , Maggie Chang
- & Jen-Chywan Wang
Nature Communications 14, 3143
Research
29 May 2023 | Open Access

Trends in diabetes incidence in Austria 2013–2017
- Michaela Kaleta
- , Michael Leutner
- & Alexandra Kautzky-Willer
Scientific Reports 13, 8715
Research
29 May 2023 | Open Access

Three genes expressed in relation to lipid metabolism considered as potential biomarkers for the diagnosis and treatment of diabetic peripheral neuropathy
- Ye Yang
- & Qin Wang
Scientific Reports 13, 8679
Research
27 May 2023 | Open Access

Predicting glycemic control status and high blood glucose levels through voice characteristic analysis in patients with cystic fibrosis-related diabetes (CFRD)
- Pichatorn Suppakitjanusant
- , Nittaya Kasemkosin
- & Vin Tangpricha
Scientific Reports 13, 8617

All Research & Reviews

News and Comment

Research Highlights | 31 May 2023

Liver–bone crosstalk implicated in osteoporosis progression
- Olivia Tysoe
Nature Reviews Endocrinology, 1
Comments & Opinion | 31 May 2023

Therapeutic inertia in type 2 diabetes mellitus: a fine line between advancing and de-intensifying

Type 2 diabetes mellitus is a progressive disease requiring regular monitoring and therapeutic changes. It is important that healthcare professionals embrace both ends of the spectrum of therapeutic inertia, including appropriate advancement and de-intensification of therapies.
- Kamlesh Khunti
- & Alice Y. Y. Cheng
Nature Reviews Endocrinology, 1-2
News & Views | 30 May 2023

Zooming into process-specific risk

Functional genomic analyses reveal a complex relationship between the COBLL1 gene and metabolic health, as well as how the same variant can both reduce body fat and increase the risk of type 2 diabetes.
- Hannah Maude
- & Inês Cebola
Nature Metabolism 5, 730-731
Research Highlights | 26 May 2023

A mitochondrial origin for inherited diabetes mellitus
- Brandon J. Berry
Nature Reviews Endocrinology, 1
Comments & Opinion | 24 May 2023

Artificial intelligence in diabetes mellitus and endocrine diseases — what can we expect?

Artificial intelligence has already revolutionized various fields in medicine and research. Due to the complex and interconnected nature of the endocrine system, it is an ideal area to further exploit and maximize the potential benefits of artificial intelligence.
- Ioannis T. Oikonomakos
- , Charlotte Steenblock
- & Stefan R. Bornstein
Nature Reviews Endocrinology 19, 375-376
Research Highlights | 23 May 2023

Gut microbiota influences effectiveness of anti-diabetic drug
- Claire Greenhill
Nature Reviews Endocrinology 19, 379

All News & Comment

Endocrine system and metabolic diseases articles from across Nature Portfolio

Featured

Zooming into process-specific risk

How can social jetlag affect health?

Latest Research and Reviews

Protocol development to further differentiate and transition stem cell-derived pancreatic progenitors from a monolayer into endocrine cells in suspension culture

A versatile bioelectronic interface programmed for hormone sensing

Transcriptional coactivation by EHMT2 restricts glucocorticoid-induced insulin resistance in a study with male mice

Trends in diabetes incidence in Austria 2013–2017

Three genes expressed in relation to lipid metabolism considered as potential biomarkers for the diagnosis and treatment of diabetic peripheral neuropathy

Predicting glycemic control status and high blood glucose levels through voice characteristic analysis in patients with cystic fibrosis-related diabetes (CFRD)

News and Comment

Liver–bone crosstalk implicated in osteoporosis progression

Therapeutic inertia in type 2 diabetes mellitus: a fine line between advancing and de-intensifying

Zooming into process-specific risk

A mitochondrial origin for inherited diabetes mellitus

Artificial intelligence in diabetes mellitus and endocrine diseases — what can we expect?

Gut microbiota influences effectiveness of anti-diabetic drug

Search

Quick links

Endocrine system and metabolic diseases articles from across Nature Portfolio

Featured

Related Subjects

Latest Research and Reviews

News and Comment

Search

Quick links